A carregar...
Dasatinib-induced pleural effusion: Chylothorax, an option to consider
Dasatinib is a drug for treatment of oncogene fusion protein BCR-ABL-positive chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant/intolerant to imatinib. Pleural effusion (PE) is a common adverse effect, and in this context, we present four cases seen...
Na minha lista:
| Publicado no: | Ann Thorac Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5070439/ https://ncbi.nlm.nih.gov/pubmed/27803756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1817-1737.191871 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|